Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McGill University

$380,219.00

FBW7-dependent regulation of cMYC and MXD1 function by the vitamin D receptor

EF 2012-13

Résumé
Growing epidemiological evidence suggests that maintaining vitamin D sufficiency reduces the risk of developing certain types of cancers, particularly cancers of the digestive tract. We have been interested in how the active form of vitamin D can control cancer cell proliferation, and have found that it inhibits both the production and function of cMYC in cancer cells through inhibiting the rate of production of new cMYC protein and through reducing the stability of existing cMYC protein. We also found that vitamin D stimulates the production and function of an antagonist of cMYC called MAD1/MXD1. Our goals are to understand in full the molecular mechanisms by which vitamin D controls cMYC and MXD1 function. These studies are important because they will provide a molecular basis for the potential cancer chemopreventive activities of vitamin D.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
279017
Name
White John H
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
FBW7-dependent regulation of cMYC and MXD1 function by the vitamin D receptor
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$380,219
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Chipseq; Cmyc; Fbw7; Gene Expression Profiling; Mxd1; Signal Transduction; Vitamin D
Abstract
Growing epidemiological evidence suggests that maintaining vitamin D sufficiency reduces the risk of developing certain types of cancers, particularly cancers of the digestive tract. We have been interested in how the active form of vitamin D can control cancer cell proliferation, and have found that it inhibits both the production and function of cMYC in cancer cells through inhibiting the rate of production of new cMYC protein and through reducing the stability of existing cMYC protein. We also found that vitamin D stimulates the production and function of an antagonist of cMYC called MAD1/MXD1. Our goals are to understand in full the molecular mechanisms by which vitamin D controls cMYC and MXD1 function. These studies are important because they will provide a molecular basis for the potential cancer chemopreventive activities of vitamin D.
Competitiondate
201303
Approvedterm2
3 yrs 0 mth
Pinamesdelim
White, John H
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $380,219~ $0~